These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1329254)

  • 1. Hypersensitivity of diabetic human platelets to platelet activating factor.
    Shukla SD; Paul A; Klachko DM
    Thromb Res; 1992 May; 66(2-3):239-46. PubMed ID: 1329254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    Shukla SD; Morrison WJ; Dhar A
    Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
    Nunez D; Randon J; Gandhi C; Siafaka-Kapadai A; Olson MS; Hanahan DJ
    J Biol Chem; 1990 Oct; 265(30):18330-8. PubMed ID: 2170407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ; Shukla SD
    J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A; Paul AK; Shukla SD
    Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
    Salari H; Dryden P; Howard S; Bittman R
    Biochem Cell Biol; 1992 Feb; 70(2):129-35. PubMed ID: 1324692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.
    Hwang SB
    J Biol Chem; 1988 Mar; 263(7):3225-33. PubMed ID: 2830276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ethanol on human platelets stimulated with platelet-activating factor, a biologically active ether phospholipid.
    Baker RC; Fish HT; Fitzpatrick FA
    Alcohol Clin Exp Res; 1989 Dec; 13(6):824-8. PubMed ID: 2557776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity.
    Shukla SD; Morrison WJ; Klachko DM
    Transfusion; 1989; 29(6):528-33. PubMed ID: 2546298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
    Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
    [No Abstract]   [Full Text] [Related]  

  • 12. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.
    Carrick JB; Morris DD; Moore JN
    Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD; Moore JN
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific, photolabile and irreversible antagonist (L662,025) of the PAF-receptor.
    Hussaini IM; Shen TY
    Biochem Biophys Res Commun; 1989 May; 161(1):23-30. PubMed ID: 2543410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
    Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
    J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood.
    Chan WP; Levy JV
    Prostaglandins; 1991 Oct; 42(4):337-42. PubMed ID: 1665568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.